Abbott ’ s FreeStyle Libre glucose monitoring app launches in Europe
Abbott (NYSE:ABT) said today that it launched an app for its FreeStyle Libre glucose monitoring system in Europe that can be used with both iPhone and Android smartphones. The mobile app is designed to give people with diabetes direct access to their glucose data on their smartphones. Without the app, FreeStyle Libre users have to carry a separate, handheld device to scan the system’s sensor for a glucose reading. Get the full story at our sister site, Drug Delivery Business News. The post Abbott’s FreeStyle Libre glucose monitoring app launches in Europe appeared first on MassDevice.